Corium Innovations showcases next-generation transdermal and oral thin film drug delivery and manufacturing capabilities at Bio International Convention

Grand Rapids, Michigan, June 9, 2025 – Corium Innovations, Inc., a leading, full-service contract development and manufacturing organization specializing in novel drug delivery technologies, announced today that its industry leading 7-day transdermal and oral thin film technologies will be featured in the Michigan Economic Development Corp. Pavilion #2835 during the prestigious 2025 BIO International Convention, to be held June 16-19 in Boston.

“Our team is proud to develop and manufacture products right here in the U.S.— and especially in Michigan, where tailored innovation and efficient manufacturing come together to support our partners’ most complex needs. We’re committed to advancing drug delivery solutions that improve patient outcomes while providing flexible, high-impact support across both branded and complex generic markets,” said Dr. Mark Sirgo, Chief Executive Officer at Corium Innovations.

With annual manufacturing capacity of more than 200 million transdermal patches/films at its 200,000 square foot, FDA, DEA and ISO registered facility in Grand Rapids, Michigan, Corium Innovations maintains fully integrated research, development, and analytical capabilities. Corium Innovations, with 25 years of developing and manufacturing groundbreaking transdermal and oral thin film delivery systems including over 100+ patents, brings the best of these proprietary delivery platforms to different patient and consumer groups in customary or challenging usage situations.

Corium Innovations’ proprietary Corplex® transdermal innovation platform breaks new ground in drug delivery with a proprietary mix of adhesives, polymers and liners that can be adjusted for almost any use situation. From Crest® brand teeth whitening strips, to the first and only 7-day, low-dose estrogen birth control patch, Corplex® is helping millions of people get the help and benefits they are seeking in a way that works better for their lives.

About Corium Innovations

Headquartered in Grand Rapids, Michigan, Corium Innovations is a leading, full-service contract development and manufacturing organization specializing in novel drug delivery technologies. With a track record spanning nearly 30 years, Corium Innovations offers end-to-end solutions to its partners, from formulation and product development work, through commercial-scale manufacturing and packaging. The company's success is enabled by its state-of-the-art facilities, highly tenured operational leadership, and its proprietary proven drug delivery technology Corplex®. For more information, visit www.coriuminv.com.

About Gurnet Point Capital

Point Capital is a leading healthcare fund that invests in de-risked life sciences companies. Gurnet Point primarily focuses on businesses that have high growth potential in the late product development and commercialization stages of their evolution. These companies become partners not just because of their capacity to generate economic value, but also because of their potential to deliver social impact. Gurnet Point’s team of highly experienced industry executives works closely with its portfolio companies, with an active approach driving operational transformation and outsized returns. For more information, visit www.gurnetpointcapital.com.

About Webster Equity Partners

healthcare organizations dedicated to providing best of class clinical care and service to their patients. For more information, visit www.websterequitypartners.com.

Contact

Gartman PR
gartmanpr@gmail.com
202-413-4226